These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10608783)

  • 1. Amantadine and rimantadine have no direct inhibitory effects against hepatitis C viral protease, helicase, ATPase, polymerase, and internal ribosomal entry site-mediated translation.
    Jubin R; Murray MG; Howe AY; Butkiewicz N; Hong Z; Lau JY
    J Infect Dis; 2000 Jan; 181(1):331-4. PubMed ID: 10608783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amantadine inhibits hepatitis A virus internal ribosomal entry site-mediated translation in human hepatoma cells.
    Kanda T; Yokosuka O; Imazeki F; Fujiwara K; Nagao K; Saisho H
    Biochem Biophys Res Commun; 2005 Jun; 331(2):621-9. PubMed ID: 15850805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of proteasome alpha-subunit PSMA7 in hepatitis C virus internal ribosome entry site-mediated translation.
    Krüger M; Beger C; Welch PJ; Barber JR; Manns MP; Wong-Staal F
    Mol Cell Biol; 2001 Dec; 21(24):8357-64. PubMed ID: 11713272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway.
    Kato J; Kato N; Moriyama M; Goto T; Taniguchi H; Shiratori Y; Omata M
    J Infect Dis; 2002 Jul; 186(2):155-63. PubMed ID: 12134250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of hepatitis C virus IRES-mediated translation by oligonucleotides.
    Li X; Mueller S; Wimmer E
    Virus Res; 2009 Dec; 146(1-2):29-35. PubMed ID: 19720092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of internal ribosomal entry site-directed translation of HCV by recombinant IFN-alpha correlates with a reduced La protein.
    Shimazaki T; Honda M; Kaneko S; Kobayashi K
    Hepatology; 2002 Jan; 35(1):199-208. PubMed ID: 11786977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation.
    Dash S; Prabhu R; Hazari S; Bastian F; Garry R; Zou W; Haque S; Joshi V; Regenstein FG; Thung SN
    Liver Int; 2005 Jun; 25(3):580-94. PubMed ID: 15910496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A peptide derived from RNA recognition motif 2 of human la protein binds to hepatitis C virus internal ribosome entry site, prevents ribosomal assembly, and inhibits internal initiation of translation.
    Pudi R; Ramamurthy SS; Das S
    J Virol; 2005 Aug; 79(15):9842-53. PubMed ID: 16014945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between translation efficiency and outcome of combination therapy in chronic hepatitis C genotype 3.
    Yasmeen A; Hamid S; Granath FN; Lindström H; Elliott RM; Siddiqui AA; Persson MA
    J Viral Hepat; 2006 Feb; 13(2):87-95. PubMed ID: 16436126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment.
    Soler M; McHutchison JG; Kwoh TJ; Dorr FA; Pawlotsky JM
    Antivir Ther; 2004 Dec; 9(6):953-68. PubMed ID: 15651754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
    Jarczak D; Korf M; Beger C; Manns MP; Krüger M
    FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing and analysis of a potent bi-functional aptamers that inhibit protease and helicase activities of HCV NS3.
    Umehara T; Fukuda K; Nishikawa F; Sekiya S; Kohara M; Hasegawa T; Nishikawa S
    Nucleic Acids Symp Ser (Oxf); 2004; (48):195-6. PubMed ID: 17150545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro.
    Alotte C; Martin A; Caldarelli SA; Di Giorgio A; Condom R; Zoulim F; Durantel D; Hantz O
    Antiviral Res; 2008 Dec; 80(3):280-7. PubMed ID: 18625270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of the internal ribosome entry site (IRES)-mediated translation of the hepatitis C virus: critical role of binding of the stem-loop IIId domain of IRES and the viral core protein.
    Shimoike T; Koyama C; Murakami K; Suzuki R; Matsuura Y; Miyamura T; Suzuki T
    Virology; 2006 Feb; 345(2):434-45. PubMed ID: 16297950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting internal ribosome entry site (IRES)-mediated translation to block hepatitis C and other RNA viruses.
    Dasgupta A; Das S; Izumi R; Venkatesan A; Barat B
    FEMS Microbiol Lett; 2004 May; 234(2):189-99. PubMed ID: 15135522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of the interferon alpha response against hepatitis C virus replicons.
    Guo JT; Sohn JA; Zhu Q; Seeger C
    Virology; 2004 Jul; 325(1):71-81. PubMed ID: 15231387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potent and specific morpholino antisense inhibitor of hepatitis C translation in mice.
    McCaffrey AP; Meuse L; Karimi M; Contag CH; Kay MA
    Hepatology; 2003 Aug; 38(2):503-8. PubMed ID: 12883495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. hnRNP L is required for the translation mediated by HCV IRES.
    Hwang B; Lim JH; Hahm B; Jang SK; Lee SW
    Biochem Biophys Res Commun; 2009 Jan; 378(3):584-8. PubMed ID: 19061868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects on the hepatitis C virus (HCV) internal ribosome entry site by vitamin B12 and the HCV core protein.
    Li D; Lott WB; Martyn J; Haqshenas G; Gowans EJ
    J Virol; 2004 Nov; 78(21):12075-81. PubMed ID: 15479850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autogenous translational inhibition of core protein: implication for switch from translation to RNA replication in hepatitis C virus.
    Zhang J; Yamada O; Yoshida H; Iwai T; Araki H
    Virology; 2002 Feb; 293(1):141-50. PubMed ID: 11853407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.